Predicting potential adverse events using safety data from marketed drugs

摘要

Characteristics of test drugs, comparator drugs and test-comparator drug combinations. ) Distribution of number of comparator drugs for test drug. ) Distribution of time on market for test drugs. ) Tanimoto score distribution for test-comparator drug combinations. ) Target similarity score distribution for test-comparator drug combinations. ) Distribution of time on market for comparator drugs